Standard Historical Financial Ratios

LAB Stock  USD 1.85  0.02  1.09%   
Standard Biotools is promptly reporting on over 102 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 83.29 will help investors to properly organize and evaluate Standard Biotools financial condition quickly.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Standard Biotools. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For information on how to trade Standard Stock refer to our How to Trade Standard Stock guide.

About Standard Financial Ratios Analysis

Standard BiotoolsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Standard Biotools investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Standard financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Standard Biotools history.

Standard Biotools Financial Ratios Chart

At present, Standard Biotools' PTB Ratio is projected to slightly decrease based on the last few years of reporting. The current year's Days Sales Outstanding is expected to grow to 83.29, whereas Price To Sales Ratio is forecasted to decline to 1.56.
Add Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Standard Biotools stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Standard Biotools sales, a figure that is much harder to manipulate than other Standard Biotools multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Dividend Yield

Dividend Yield is Standard Biotools dividend as a percentage of Standard Biotools stock price. Standard Biotools dividend yield is a measure of Standard Biotools stock productivity, which can be interpreted as interest rate earned on an Standard Biotools investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.

Book Value Per Share

The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.

Invested Capital

Invested capital represents the total cash investment that shareholders and debt holders have contributed to Standard Biotools. There are two different methods for calculating Standard Biotools invested capital: operating approach and financing approach. Understanding Standard Biotools invested capital allows investors to calculate measures of performance such as return on invested capital or return on capital employed.
Most ratios from Standard Biotools' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Standard Biotools current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Standard Biotools. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For information on how to trade Standard Stock refer to our How to Trade Standard Stock guide.At present, Standard Biotools' PTB Ratio is projected to slightly decrease based on the last few years of reporting. The current year's Days Sales Outstanding is expected to grow to 83.29, whereas Price To Sales Ratio is forecasted to decline to 1.56.
 2021 2022 2023 2024 (projected)
Payables Turnover5.777.696.055.16
Days Of Inventory On Hand124.19128.7134.09197.1

Standard Biotools fundamentals Correlations

0.730.030.050.360.030.840.730.980.01-0.23-0.220.050.1-0.370.220.24-0.84-0.81-0.82-0.890.26-0.370.03-0.84-0.94
0.73-0.440.410.720.40.441.00.80.39-0.460.210.39-0.330.16-0.06-0.19-0.69-0.66-0.65-0.75-0.21-0.55-0.51-0.7-0.76
0.03-0.44-0.54-0.34-0.590.35-0.44-0.05-0.6-0.03-0.74-0.540.73-0.650.290.660.260.270.210.250.710.620.30.260.17
0.050.41-0.540.680.99-0.070.410.080.99-0.050.620.98-0.910.4-0.39-0.91-0.12-0.12-0.06-0.17-0.73-0.24-0.21-0.12-0.21
0.360.72-0.340.680.660.230.720.40.65-0.720.410.69-0.570.24-0.16-0.53-0.25-0.22-0.24-0.32-0.41-0.19-0.69-0.26-0.39
0.030.4-0.590.990.66-0.120.40.051.0-0.030.660.99-0.930.39-0.41-0.94-0.15-0.16-0.1-0.19-0.72-0.3-0.19-0.16-0.22
0.840.440.35-0.070.23-0.120.440.79-0.14-0.19-0.46-0.080.27-0.630.480.36-0.48-0.44-0.51-0.550.460.050.15-0.48-0.66
0.731.0-0.440.410.720.40.440.80.39-0.460.210.39-0.330.16-0.06-0.19-0.69-0.66-0.65-0.75-0.21-0.55-0.51-0.7-0.76
0.980.8-0.050.080.40.050.790.80.03-0.27-0.170.050.05-0.270.240.23-0.82-0.78-0.79-0.870.17-0.44-0.07-0.82-0.91
0.010.39-0.60.990.651.0-0.140.390.03-0.010.670.99-0.930.4-0.43-0.94-0.14-0.15-0.08-0.18-0.73-0.29-0.19-0.14-0.2
-0.23-0.46-0.03-0.05-0.72-0.03-0.19-0.46-0.27-0.010.04-0.09-0.050.02-0.09-0.010.090.060.120.13-0.09-0.10.830.090.17
-0.220.21-0.740.620.410.66-0.460.21-0.170.670.040.63-0.880.75-0.5-0.70.060.060.120.03-0.82-0.41-0.210.050.07
0.050.39-0.540.980.690.99-0.080.390.050.99-0.090.63-0.90.31-0.38-0.93-0.16-0.17-0.11-0.2-0.66-0.23-0.2-0.16-0.23
0.1-0.330.73-0.91-0.57-0.930.27-0.330.05-0.93-0.05-0.88-0.9-0.610.440.90.050.05-0.010.080.860.380.190.050.08
-0.370.16-0.650.40.240.39-0.630.16-0.270.40.020.750.31-0.61-0.55-0.440.230.220.310.21-0.87-0.32-0.40.220.27
0.22-0.060.29-0.39-0.16-0.410.48-0.060.24-0.43-0.09-0.5-0.380.44-0.550.4-0.13-0.11-0.32-0.120.430.080.17-0.13-0.15
0.24-0.190.66-0.91-0.53-0.940.36-0.190.23-0.94-0.01-0.7-0.930.9-0.440.4-0.03-0.01-0.05-0.020.730.230.2-0.02-0.02
-0.84-0.690.26-0.12-0.25-0.15-0.48-0.69-0.82-0.140.090.06-0.160.050.23-0.13-0.031.00.970.99-0.110.61-0.051.00.96
-0.81-0.660.27-0.12-0.22-0.16-0.44-0.66-0.78-0.150.060.06-0.170.050.22-0.11-0.011.00.960.98-0.110.59-0.071.00.94
-0.82-0.650.21-0.06-0.24-0.1-0.51-0.65-0.79-0.080.120.12-0.11-0.010.31-0.32-0.050.970.960.96-0.170.63-0.060.970.93
-0.89-0.750.25-0.17-0.32-0.19-0.55-0.75-0.87-0.180.130.03-0.20.080.21-0.12-0.020.990.980.96-0.080.61-0.030.990.98
0.26-0.210.71-0.73-0.41-0.720.46-0.210.17-0.73-0.09-0.82-0.660.86-0.870.430.73-0.11-0.11-0.17-0.080.360.26-0.11-0.1
-0.37-0.550.62-0.24-0.19-0.30.05-0.55-0.44-0.29-0.1-0.41-0.230.38-0.320.080.230.610.590.630.610.360.050.620.51
0.03-0.510.3-0.21-0.69-0.190.15-0.51-0.07-0.190.83-0.21-0.20.19-0.40.170.2-0.05-0.07-0.06-0.030.260.05-0.05-0.02
-0.84-0.70.26-0.12-0.26-0.16-0.48-0.7-0.82-0.140.090.05-0.160.050.22-0.13-0.021.01.00.970.99-0.110.62-0.050.96
-0.94-0.760.17-0.21-0.39-0.22-0.66-0.76-0.91-0.20.170.07-0.230.080.27-0.15-0.020.960.940.930.98-0.10.51-0.020.96
Click cells to compare fundamentals

Standard Biotools Account Relationship Matchups

Standard Biotools fundamentals Accounts

201920202021202220232024 (projected)
Price To Sales Ratio1.983.132.280.941.651.56
Ptb Ratio1.513.113.14(1.12)1.072.08
Days Sales Outstanding59.0967.1751.2164.3967.4883.29
Book Value Per Share2.31.931.25(1.04)2.062.16
Free Cash Flow Yield(0.16)(0.0651)(0.19)(1.02)(0.26)(0.28)
Operating Cash Flow Per Share(0.53)(0.21)(0.58)(1.14)(0.55)(0.57)
Stock Based Compensation To Revenue0.08920.09760.09720.10.120.08
Capex To Depreciation0.160.80.850.250.190.18
Pb Ratio1.513.113.14(1.12)1.072.08
Ev To Sales2.313.322.911.152.081.98
Free Cash Flow Per Share(0.57)(0.39)(0.76)(1.19)(0.58)(0.61)
Inventory Turnover3.812.782.942.842.722.01
Net Income Per Share(0.97)(0.74)(0.78)(2.43)(0.94)(0.99)
Days Of Inventory On Hand95.68131.1124.19128.7134.09197.1
Payables Turnover10.285.955.777.696.055.16
Capex To Revenue0.01590.0032930.02160.09210.02660.0253
Cash Per Share0.880.950.382.121.451.38
Pocfratio(6.6)(28.04)(6.74)(1.03)(4.04)(4.24)
Interest Coverage(12.11)(14.29)(17.65)(26.83)(16.77)(17.61)
Capex To Operating Cash Flow(0.0148)(0.0719)(0.82)(0.0428)(0.0654)(0.0687)
Pfcf Ratio(6.16)(15.36)(5.18)(0.98)(3.79)(3.98)
Days Payables Outstanding35.561.3963.2247.4360.3288.13
Roe(0.82)(0.42)(0.38)(0.63)2.33(0.48)
Ev To Operating Cash Flow(7.69)(29.78)(8.63)(1.26)(5.12)(5.37)
Pe Ratio(3.59)(8.15)(5.02)(0.48)(2.34)(2.46)
Return On Tangible Assets(0.53)(0.42)(0.57)(0.7)(0.35)(0.36)
Ev To Free Cash Flow(7.17)(16.32)(6.63)(1.21)(4.8)(5.04)
Earnings Yield(0.28)(0.12)(0.2)(2.07)(0.43)(0.45)
Intangibles To Total Assets0.570.450.490.30.330.36
Net Debt To E B I T D A(0.82)(0.78)(1.9)(0.12)(0.85)(0.9)
Current Ratio3.382.932.171.454.811.37
Tangible Book Value Per Share0.0495(0.11)(0.52)(2.56)0.70.74
Receivables Turnover6.185.437.135.675.414.15
Graham Number7.095.654.697.546.616.28
Shareholders Equity Per Share2.31.931.25(1.04)2.062.16
Debt To Equity0.360.410.75(0.84)0.420.8
Capex Per Share0.0490.0093820.03790.04880.03580.034

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Standard Biotools offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Standard Biotools' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Standard Biotools Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Standard Biotools Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Standard Biotools. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For information on how to trade Standard Stock refer to our How to Trade Standard Stock guide.
You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Standard Biotools. If investors know Standard will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Standard Biotools listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.69)
Revenue Per Share
0.558
Quarterly Revenue Growth
(0.14)
Return On Assets
(0.15)
Return On Equity
(0.37)
The market value of Standard Biotools is measured differently than its book value, which is the value of Standard that is recorded on the company's balance sheet. Investors also form their own opinion of Standard Biotools' value that differs from its market value or its book value, called intrinsic value, which is Standard Biotools' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Standard Biotools' market value can be influenced by many factors that don't directly affect Standard Biotools' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Standard Biotools' value and its price as these two are different measures arrived at by different means. Investors typically determine if Standard Biotools is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Standard Biotools' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.